[ Price : $8.95]
FDA warns Spains Interquim about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
Senate Judiciary Committee members led by ranking member Patrick Leahy (D-VT) introduce a bipartisan amendment to prevent pharmace...[ Price : $8.95]
Two Knobbe Martens attorneys outline reasons why a federal appeals court upheld a lower court jury ruling that a reverse payment t...[ Price : $8.95]
CDER deputy director Douglas Throckmorton says FDA is working well with stakeholders to achieve goals on the safe and appropriate ...[ Price : $8.95]
Office of New Drug associate director Leah Christl says that biosimilar companies should be aware of various regulators requiremen...[ Price : $8.95]
In its latest release of Warning Letters, FDA cites Interquim, a Spanish active pharmaceutical ingredient maker.[ Price : $8.95]
Federal Register Final Order: FDA classifies Computerized Cognitive Assessment Aids for Concussion into Class II (special controls...[ Price : $8.95]
The Foundation for the National Institutes of Health issues its Framework for Defining Evidentiary Criteria for Biomarker Qualifi...